Use of Endotracheal Tube Cuff Pressure to Assess Inspiratory Effort During Pressure Support Ventilation
NCT ID: NCT06968793
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2025-05-20
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Individualized Lung-protective Ventilation With Lung Dynamic Compliance-guided Positive End-expiratory Pressure(PEEP) Titration on Postoperative Pulmonary Complications of Pediatric Video-assisted Thoracoscopic Surgery
NCT05386901
Pressure Muscle Index and Threshold of Over-assistance During Pressure Support Ventilation
NCT06494085
Effect of Applying Cuff Air Leak Pressure as Intraoperative Cuff Pressure on Postoperative Complications
NCT04302142
Individualized PEEP Titration on Postoperative Pulmonary Complications
NCT06150079
Heart Rate Variability During Weaning From Mechanical Ventilation
NCT00851825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, despite its clinical significance, Esophageal pressure monitoring involves a relatively complex and invasive procedure. Measurement typically requires the insertion of an esophageal catheter via the nasopharyngeal or oropharyngeal route, which may cause patient discomfort and prove challenging in certain cases (e.g., esophageal pathologies or anatomical abnormalities). Consequently, while esophageal pressure remains the current gold standard for evaluating intrathoracic pressure, its clinical application faces limitations.
In contrast, Cuff pressure (Pcuff) monitoring in intubated or tracheostomized patients is simpler and routinely performed. Cuff pressure measurement primarily ensures tracheal tube sealing to prevent gas leakage and aspiration, while also reducing the risk of ventilator-associated pneumonia (VAP). Our preliminary exploratory studies have revealed correlations between Cuff pressure fluctuations and Esophageal pressure, particularly in patients undergoing pressure support ventilation. This finding suggests the potential utility of Cuff pressure as a surrogate marker for intrathoracic pressure. Esophageal pressure inherently reflects pleural pressure through Esophageal pressure changes, while the artificial airway cuff-positioned above the carina within the trachea-detects subtle pressure variations induced by adjacent muscle activity during forceful breathing. These measurements may indirectly indicate inspiratory effort. Variations in cuff positioning might influence results, and our exploratory attempts demonstrated strong waveform correlations between Cuff pressure and Esophageal pressure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pressure support 15
Pressure support of 15 cm H2O will be applied for 5 minutes.
Pressure support 15
Pressure support of 15 cm H2O will be applied for 5 minutes.
Pressure support 13
Pressure support of 13 cm H2O will be applied for 5 minutes.
Pressure support 13
Pressure support of 13 cm H2O will be applied for 5 minutes.
Pressure support 11
Pressure support of 11 cm H2O will be applied for 5 minutes.
Pressure support 11
Pressure support of 11 cm H2O will be applied for 5 minutes.
Pressure support 9
Pressure support of 9 cm H2O will be applied for 5 minutes.
Pressure support 9
Pressure support of 9 cm H2O will be applied for 5 minutes.
Pressure support 7
Pressure support of 7 cm H2O will be applied for 5 minutes.
Pressure support 7
Pressure support of 7 cm H2O will be applied for 5 minutes.
Pressure support 5
Pressure support of 5 cm H2O will be applied for 5 minutes.
Pressure support 5
Pressure support of 5 cm H2O will be applied for 5 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pressure support 15
Pressure support of 15 cm H2O will be applied for 5 minutes.
Pressure support 13
Pressure support of 13 cm H2O will be applied for 5 minutes.
Pressure support 11
Pressure support of 11 cm H2O will be applied for 5 minutes.
Pressure support 9
Pressure support of 9 cm H2O will be applied for 5 minutes.
Pressure support 7
Pressure support of 7 cm H2O will be applied for 5 minutes.
Pressure support 5
Pressure support of 5 cm H2O will be applied for 5 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Respiratory stability: Ability to breathe spontaneously and effectively clear secretions via coughing; oxygen saturation (SpO₂) \>90% or a partial pressure of oxygen (PaO₂)/FiO₂ ratio ≥150 mmHg when the ventilator's oxygen concentration is set to 40%;
3. Hemodynamic stability: Heart rate (HR) ≤120 bpm, systolic blood pressure (SBP) 90-150 mmHg, with no vasoactive agents or norepinephrine dosage ≤0.1-0.2 μg/kg·min (or equivalent doses of other vasoactive agents);
4. Metabolic stability, with an esophageal pressure monitoring catheter already placed prior to the trial;
5. Written informed consent obtained from the patient or their legal guardian.
Exclusion Criteria
2. Pregnancy;
3. Hemodynamic instability: Mean arterial pressure (MAP) \<60 mmHg, heart rate (HR) \>120 bpm or \<60 bpm;
4. Respiratory instability: Respiratory rate (RR) \>35 bpm or oxygen saturation (SpO₂) \<90%;
5. Neuromuscular disorders or phrenic nerve injury;
6. Recent trauma or surgery involving the trachea, esophagus, neck, or thorax, contraindications to esophageal catheter insertion, or inability to monitor esophageal pressure;
7. High bleeding risk: Severe coagulopathy/bleeding disorders, esophageal/gastric varices, etc.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jian-Xin Zhou
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jian-Xin Zhou
Head of Emergency and Critical Care Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jian-Xin Zhou, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Capital Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Shijitan Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIT2025-034-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.